A company still losing money with growing sales. Institutions are adding.
Going well
Sales up 22% in the latest quarter vs a year ago
Sales up 31% last year
No debt reported
Watch out for
Losing money
Share count growing 8.6% a year
Money moves
No insider buying or selling in the last 30 days
Institutions added 8.2% to their holdings in the quarter ending June 2026 (180 bought, 117 sold)
Held by Cathie Wood (ARK Invest)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$6.51+3.0% that day
Company value
$1.4B
Share price times all shares
Price vs sales
2.0x
No profit over the last year, so this compares value with sales instead
Cash vs value
7%
Cash as a share of company value
From GENI's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 4 quarters, from SEC filings
Profit, Jun '23
-$10.3M
Mar '22Tap a barJun '23
Last 12 months: -$80.4M.
What the price assumes
Your guesses, our math
Move the sliders to your own view of GENI. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$2.5B
Profit in 5 years$249M
Price these guesses point to$11.62+79% vs $6.51 todayAbout +12% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 16% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.